RefleXion featured in The Imaging Wire, October 22nd
Biotargeting oncology company, RefleXion Medical, unveiled a new “biology-guided radiotherapy” technique (BgRT), utilizing the cancer itself to guide radiation delivery.
The novel system uses PET to determine tumor location and then BgRT responds to emissions produced by the PET’s FDG tracer, potentially treating several sites simultaneously with less toxicity.
Although folks on the imaging side of the industry would call this a PET-guided treatment, the more important take-away is BgRT could significantly expand the range of patients that can be supported by radiotherapy.
– To read the article in its entirety, click here